» Call to Halt Overprescription of Medications to Elderly Patients

Call to Halt Overprescription of Medications to Elderly Patients

Moorestown, NJ (Law Firm Newswire) November 16, 2012 - During a press conference at the state Capitol, Connecticut Senator Richard Blumenthal announced his intent to halt the over-prescription of off-label antipsychotic drugs to nursing home patients.

Medical advocates and elderly care advocates also announced the formation of a Connecticut-based coalition made up of nursing home groups and public health employees. Their aim is to reduce the amount of antipsychotics prescribed to elderly patients by 15 percent, calling it "chemical restraint."

Sen. Blumenthal and the coalition of advocates, the Partnership to Improve Dementia Care in Nursing Homes, have stated that the extensive dispensing of antipsychotic medications to dementia patients, residing in long-term care facilities and nursing homes, is a form of elder abuse, no less offensive than using physical restraints. The medications in question include Olanzapine, Risperidone and Quetiapine.

Qualidigm, a Medicare quality improvement organization based in Connecticut, sponsors the coalition and Senator Bluemnthal's bill, which suggests alternative techniques for patient care, including touch therapy, music and comforting routines.

"While caring for elderly patients with dementia can bring extra challenges, we applaud the health care system taking steps to use less restrictive approaches to managing their care," stated New Jersey elder law attorney Thomas D. Begley, Jr.

The bill would require the consent from family members prior to use, and would require educational programs for prescribers and dispensing nursing home staff, as well as regular reporting on facility usage of antipsychotic drugs.
According to Blumenthal and the Partnership to Improve Dementia Care in Nursing Homes, the use of these medications for elderly dementia patients has not been approved by the FDA and can cause unresponsiveness, excessive sedation and can increase health risks such as stroke.

While the national average for prescribing these off-label antipsychotic drugs is 23.9 percent, Connecticut nursing homes currently prescribe these between 25 percent and 65 percent of the time. A report released last year by the Inspector General stated that 83 percent of nursing home care Medicare claims were for off-label conditions which included the prescribing of antipsychotic drugs.

To learn more about Begley Law Group call 1.800.533.7227 or visit www.begleylawgroup.com.

Begley Law Group, P.C.
509 S. Lenola Road, Building 7
Moorestown, NJ 08057
Tel: 800.533.7227


  • Making Special Needs Trusts Last
    By Thomas D. Begley, Jr., CELA When a personal injury victim receives a settlement, one of the biggest post-settlement problems is making the money last. If the plaintiff is receiving means-tested public benefits, the monies must be put in a Special Needs Trust. How long do the beneficiary and other family members need that money to last? When the size of the settlement is significant, best practices would dictate that a three-step process be followed: Counseling Session.  A counseling session should be held with the person with disabilities, the family members, if appropriate, the trustee, the attorney drafting the Special [...]
  • The Future of the Practice of Law
    By Thomas D. Begley, Jr., CELA A Virginia State Bar Association appointed a study committee on the future of the practice of law. Perhaps New Jersey should do the same. A draft copy of the final report is interesting reading. The committee identified a number of external forces affecting the practice of law: • Advances in technology; • Increasing competition from non-lawyers; • Generational pressures as Baby Boomers begin to transition to Millennials; • Client dissatisfaction with the billable hour; • Increased in-sourcing of legal services by corporate clients; and • Accelerated globalization of legal services. Technology Serious efforts are now [...]
  • Third Party Special Needs Trusts
    By Thomas D. Begley, Jr., CELA A Third Party Special Needs Trust is usually used in a Medicaid context not for the benefit of the grantor of the trust, but for the beneficiary. The grantor of the trust is typically a parent, but could be grandparent, sibling, other relative or friend. The grantor uses the grantor’s assets to fund the trust. The assets of the beneficiary cannot be used to fund a Third Party Special Needs Trust. In order for the trust to be a Special Needs Trust, the beneficiary must be disabled. Disability is usually determined ,y the fact that [...]

See other news sources publishing this article. BETA | Tags: , , , , , , , , , , , ,



Get headlines from Law Firm Newswire sent right to your inbox.

* indicates required